PRIMARY INDICATIONS FOR USE IN THE DOG AND CAT ARE:

• Urinary tract infections including infections with E.coli, Proteus spp., Klebsiella spp., Pseudomonas aeruginosa, Staph spp., and Group D streptococcus.
• Respiratory infections, including infections with E.coli, Streptococcus spp., Pasteurella spp., Klebsiella spp., Pseudomonas spp., Bordetella bronchiseptica, Staphylococcus spp.
• Deep pyodermas caused by Staph. intermedius including those infected with secondary invaders.
• Wounds, abscesses and discharging sinuses.

Enro 50mg/mL Injection is especially useful in cats for treating serious antibiotic resistant infections of the respiratory tract or genito-urinary system, particularly chronic urinary tract infections. In cats it is also useful for deep pyodermas, osteomyelitis and Gram negative septicaemias.

 Enro 50mg/mL Injection may also be used in exotic animals (small mammals, reptiles and avian species) for the treatment of bacterial infections of the alimentary and respiratory tracts where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

DOGS & CATS

The optimum dose of Enro 50mg/mL Injection in dogs and cats is 5 mg/kg of body weight (1 ml per 10 kg bodyweight) administered once daily.

Enro 50mg/mL Injection should be administered subcutaneously and normal sterile precautions should be taken.

In simple infections, Enro 50mg/mL Injection should be given for 2-3 days beyond the cessation of clinical signs. Enro 50mg/mL Injection may be used as the initial dose. If no improvement is seen within five days, the diagnosis should be re-evaluated and a different course of therapy considered. In deep or complex infections, eg pyodermas and discharging sinuses, extended courses may be required and progress should be regularly reviewed.